2024 Presenter Profiles
Towards Innovative and Equitable Care in Youth-Onset Type 2 Diabetes
Monday, June 24, at 8:00 a.m. ET
Room W315
Orange County Convention Center
Advances in Pathophysiology and Novel Treatments in Youth-Onset Type 2 Diabetes
Stephanie T. Chung, MBBS
Lasker Clinical Investigator,
National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health
What is your presentation about?
The number of youths with type 2 diabetes is rapidly increasing worldwide. This emerging public health burden is associated with high complication rates and substantial social, personal, and financial stress. This session will discuss new advances in understanding the social and biological underpinnings of youth-onset type 2 diabetes, spotlight novel therapies for controlling this chronic disease, and briefly discuss areas for future research.
How do you hope your presentation will impact diabetes research or care?
Management of pediatric type 2 diabetes is rapidly evolving. This presentation will help guide therapeutic decision-making and future research endeavors by sharing the latest advances in research and medication regimens.
How did you become involved with this area of diabetes research or care?
I have been taking care of youth with diabetes for over 15 years and am passionate about helping youth reach their fullest potential. Unfortunately, youth with type 2 diabetes often face many social, emotional, and medication challenges when managing their diabetes. Our program aims to alleviate some of the burden by providing targeted comprehensive care and research.
